Literature DB >> 12508369

Influence of intrauterine injection of rat fetal hepatocytes on rejection of rat liver transplantation.

Yan-Ling Yang1, Ke-Feng Dou, Kai-Zong Li.   

Abstract

AIM: To investigate the influence of immune tolerance induced by intrauterine exposure to fetal hepatocytes on liver transplantation in the adult rat.
METHODS: LOU/CN rat fetal hepatocytes were injected into the fetuses of pregnant CHN rats (14-16 days of gestation). At 7-9 weeks of age, the surviving male rats received orthotopic liver transplantation (OLT) from male LOU/CN donors and the survival period was observed and monitered by mixed lymphocyte reaction assay and cytotoxicity test.
RESULTS: (1) A total of 31 pregnant CHN rats with 172 fetuses received fetal hepatocytes from LOU/CN rats via intrauterine injection. Among them, thirteen pregnant rats showed normal parturition, with 74 neonatal rats growing up normally. (2) The mean survival period after OLT in rats with fetal exposure to fetal hepatocytes was 32.1+/-3.7 days, which was significantly different from the control (11.8+/-2.3 days, P<0.01) in rats without fetal induction of immune tolerance. (3) Mixed lymphocyte proliferation assays yielded remarkable discrepancies between the groups of rats with- or without fetal exposure to fetal hepatocytes, with values of 8,411+/-1,361 and 22,473+/-1,856 (CPM+/-SD, P<0.01) respectively. (4) Cytotoxicity assays showed values of 21.2+/-6.5 % and 64.5+/-7.2 % (P<0.01) in adult rats with or without fetal induction of immune tolerance.
CONCLUSION: Intrauterine injection of fetal hepatocytes into rat fetuses can prolong the survival period of liver transplant adult male rats recipients, inducting immune tolerance in OLT.

Entities:  

Mesh:

Year:  2003        PMID: 12508369      PMCID: PMC4728228          DOI: 10.3748/wjg.v9.i1.137

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  50 in total

Review 1.  Haematopoietic stem cell transplantation and gene therapy in the fetus: ready for clinical use?

Authors:  D V Surbek; W Holzgreve; K H Nicolaides
Journal:  Hum Reprod Update       Date:  2001 Jan-Feb       Impact factor: 15.610

2.  Transplantation of primary and reversibly immortalized human liver cells and other gene therapies in acute liver failure and decompensated chronic liver disease.

Authors:  Stephen M Riordan; Roger Williams
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

3.  A successful case of combined liver and kidney transplantation for autosomal dominant polycystic liver and kidney disease.

Authors:  Xiao-Shun He; Jie-Fu Huang; Gui-Hua Chen; Ke-Li Zheng; Xiao-Ming Ye
Journal:  World J Gastroenterol       Date:  1999-02       Impact factor: 5.742

Review 4.  Long-term care of pediatric renal transplant patients: from bench to bedside.

Authors:  Dmitry Samsonov; David M Briscoe
Journal:  Curr Opin Pediatr       Date:  2002-04       Impact factor: 2.856

5.  Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients.

Authors:  Patricia A Taylor; Ronald T McElmurry; Christopher J Lees; David E Harrison; Bruce R Blazar
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

Review 6.  The role of the graft in establishing tolerance.

Authors:  Mahzuz Karim; Ulrich Steger; Andrew R Bushell; Kathryn J Wood
Journal:  Front Biosci       Date:  2002-05-01

Review 7.  In utero transplantation for thalassemia.

Authors:  A W Flake; E D Zanjani
Journal:  Ann N Y Acad Sci       Date:  1998-06-30       Impact factor: 5.691

Review 8.  Growth following solid-organ transplantation.

Authors:  Richard N Fine
Journal:  Pediatr Transplant       Date:  2002-02

9.  HMG-CoA reductase inhibitor cerivastatin prolonged rat cardiac allograft survival by blocking intercellular signals.

Authors:  Hitoshi Horimoto; Yasunari Nakai; Ken ich Nakahara; Yukiya Nomura; Shigetoshi Mieno; Shinjiro Sasaki
Journal:  J Heart Lung Transplant       Date:  2002-04       Impact factor: 10.247

Review 10.  The management of patients with the short bowel syndrome.

Authors:  Cameron F E Platell; Jane Coster; Rosalie D McCauley; John C Hall
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

View more
  4 in total

1.  Influence of liver nonparenchymal cell infusion combined with cyclosporin A on rejection of rat small bowel transplantation.

Authors:  Yan-Ling Yang; Ji-Peng Li; Ke-Feng Dou; Kai-Zong Li
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

2.  Protective effect of exogenous adenosine triphosphate on hypothermically preserved rat liver.

Authors:  Xiao-Dong Tan; Hiroshi Egami; Feng-Shan Wang; Michio Ogawa
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

3.  Targeting Metabolism as a Platform for Inducing Allograft Tolerance in the Absence of Long-Term Immunosuppression.

Authors:  Chih-Hsien Cheng; Chen-Fang Lee; Byoung Chol Oh; Georg J Furtmüller; Chirag H Patel; Gerald Brandacher; Jonathan D Powell
Journal:  Front Immunol       Date:  2020-04-09       Impact factor: 7.561

4.  In utero hepatocellular transplantation in rats.

Authors:  Emma Muñoz-Sáez; Estefanía de Munck; Paloma Maganto; Cristina Escudero; Begoña G Miguel; Rosa María Arahuetes
Journal:  Clin Dev Immunol       Date:  2013-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.